Some medications like liraglutide, dulaglutide, and semaglutide have proven cardiovascular benefits, along with other benefits such as appetite suppression, weight management, and glycemic control
There was an absence of standardization in what constituted the eye evaluations, how they were performed and their intervals
Peptide Therapy may not be appropriate for everyone
GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
Can it be combined with other IV therapies
Buyers assume responsibility for their own decisions about use